Patients must have anticipated life expectancy greater than 3 months
Have ECOG PS of 0 or 1 with an anticipated life expectancy of > 6 months.
Have an anticipated life expectancy of ?3 months.
Anticipated life expectancy greater than 6 months
Anticipated life expectancy of at least 3 months
Subject has anticipated life expectancy > 6 months prior to leukapheresis and >3 months prior to lymphodepletion.
Anticipated life expectancy of more than 3 months per Investigator's judgement
Anticipated life expectancy >= three months
Subject has anticipated life expectancy > 6 months prior to leukapheresis and >3 months prior to lymphodepletion.
Subject has an ECOG Performance Status 0-1 and anticipated life expectancy >6 months prior to apheresis and >3 months prior to lymphodepletion.
Anticipated life expectancy >12 weeks
Anticipated life expectancy of at least 3 months
Anticipated life expectancy of greater than 3 months
Have an anticipated life expectancy of greater than 8 weeks.
ECOG Performance Status 0-1 and anticipated life expectancy > 3 months.
Have an anticipated life expectancy of ?3 months.
Have ECOG PS of 0 or 1 with an anticipated life expectancy of > 6 months.
Patients must have an anticipated life expectancy > 3 months.
Anticipated life expectancy >= 6 months
Anticipated life expectancy ? 12 weeks
Have an anticipated life expectancy of greater than 6 months
Anticipated life expectancy of at least three months;
Anticipated life expectancy >3 months at the time of screening
Anticipated life expectancy >3 months at the time of screening
Anticipated life expectancy of at least 12 weeks
Anticipated life expectancy >12 weeks
Anticipated life expectancy > 3 months at the time of screening
Anticipated life expectancy of >12 weeks
Anticipated life expectancy of greater than 3 months
Have a life expectancy >12 months from the anticipated time of initiation of treatment
Patients with anticipated life expectancy < 3 months will be excluded
